Podchaser Logo
Home
The Great Potential of Bacteriophages to Replace Antibiotics (Interview with Dr. Steven Theriault, CEO and Chief Scientific Officer of Cytophage Technologies)

The Great Potential of Bacteriophages to Replace Antibiotics (Interview with Dr. Steven Theriault, CEO and Chief Scientific Officer of Cytophage Technologies)

Released Wednesday, 4th May 2022
Good episode? Give it some love!
The Great Potential of Bacteriophages to Replace Antibiotics (Interview with Dr. Steven Theriault, CEO and Chief Scientific Officer of Cytophage Technologies)

The Great Potential of Bacteriophages to Replace Antibiotics (Interview with Dr. Steven Theriault, CEO and Chief Scientific Officer of Cytophage Technologies)

The Great Potential of Bacteriophages to Replace Antibiotics (Interview with Dr. Steven Theriault, CEO and Chief Scientific Officer of Cytophage Technologies)

The Great Potential of Bacteriophages to Replace Antibiotics (Interview with Dr. Steven Theriault, CEO and Chief Scientific Officer of Cytophage Technologies)

Wednesday, 4th May 2022
Good episode? Give it some love!
Rate Episode

🟦Welcome to SciSection! Joining us in today's interview is our special guest Dr. Steven Theriault, the CEO and Chief Scientific Officer of Cytophage Technologies🦠🧪! We'll be learning about his company, how he plans to use bacteriophages where antibiotics fail in the medical and agricultural industries, the use of phages in vaccinations, and so much more👀!

🟨Journalist: Amy Stewart

🟦Don’t forget to follow us on Instagram, like us on Facebook, and catch us live on the radio on CFMU 93.3 FM Wednesdays at 6 pm. For more info and SciSection content, check us out on our website!

🟨Curious about a topic? Want to hear us talk about it? Any feedback? Let us know by sending an email to [email protected]!

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features